131 related articles for article (PubMed ID: 1659413)
1. Dactinomycin is a competitive neurokinin-2 receptor antagonist.
Delay-Goyet P; Lundberg JM
Biochem Biophys Res Commun; 1991 Nov; 180(3):1342-9. PubMed ID: 1659413
[TBL] [Abstract][Full Text] [Related]
2. A potent and selective agonist for NK-2 tachykinin receptor.
Rovero P; Pestellini V; Patacchini R; Giuliani S; Santicioli P; Maggi CA; Meli A; Giachetti A
Peptides; 1989; 10(3):593-5. PubMed ID: 2550911
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition by dactinomycin of NANC sensory bronchoconstriction and [125I]NKA binding due to NK-2 receptor antagonism.
Lou YP; Delay-Goyet P; Lundberg JM
Acta Physiol Scand; 1992 Mar; 144(3):221-31. PubMed ID: 1316711
[TBL] [Abstract][Full Text] [Related]
4. FK 224, a novel cyclopeptide substance P antagonist with NK1 and NK2 receptor selectivity.
Morimoto H; Murai M; Maeda Y; Yamaoka M; Nishikawa M; Kiyotoh S; Fujii T
J Pharmacol Exp Ther; 1992 Jul; 262(1):398-402. PubMed ID: 1378096
[TBL] [Abstract][Full Text] [Related]
5. Tachykinin receptors in rabbit airways--characterization by functional, autoradiographic and binding studies.
Black JL; Diment LM; Alouan LA; Johnson PR; Armour CL; Badgery-Parker T; Burcher E
Br J Pharmacol; 1992 Oct; 107(2):429-36. PubMed ID: 1384914
[TBL] [Abstract][Full Text] [Related]
6. Novel selective agonists and antagonists confirm neurokinin NK1 receptors in guinea-pig vas deferens.
Hall JM; Morton IK
Br J Pharmacol; 1991 Feb; 102(2):511-7. PubMed ID: 1707714
[TBL] [Abstract][Full Text] [Related]
7. [Leu9 psi(CH2NH)Leu10]-neurokinin A (4-10) (MDL 28,564) distinguishes tissue tachykinin peptide NK2 receptors.
Buck SH; Harbeson SL; Hassmann CF; Shatzer SA; Rouissi N; Nantel F; van Giersbergen PL
Life Sci; 1990; 47(10):PL37-41. PubMed ID: 2170788
[TBL] [Abstract][Full Text] [Related]
8. FR 113680: a novel tripeptide substance P antagonist with NK1 receptor selectivity.
Morimoto H; Murai M; Maeda Y; Hagiwara D; Miyake H; Matsuo M; Fujii T
Br J Pharmacol; 1992 May; 106(1):123-6. PubMed ID: 1380378
[TBL] [Abstract][Full Text] [Related]
9. Role of C-terminal amidation on the biological activity of neurokinin A derivatives with agonist and antagonist properties.
Patacchini R; Quartara L; Rovero P; Goso C; Maggi CA
J Pharmacol Exp Ther; 1993 Jan; 264(1):17-21. PubMed ID: 8380857
[TBL] [Abstract][Full Text] [Related]
10. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon.
Maggi CA; Patacchini R; Meini S; Quartara L; Sisto A; Potier E; Giuliani S; Giachetti A
Br J Pharmacol; 1994 May; 112(1):150-60. PubMed ID: 7518302
[TBL] [Abstract][Full Text] [Related]
11. In vivo pharmacology of [beta Ala8]neurokinin A-(4-10), a selective NK-2 tachykinin receptor agonist.
Maggi CA; Giuliani S; Ballati L; Rovero P; Abelli L; Manzini S; Giachetti A; Meli A
Eur J Pharmacol; 1990 Feb; 177(1-2):81-6. PubMed ID: 2160369
[TBL] [Abstract][Full Text] [Related]
12. Novel ligands confirm NK-1 receptor-mediated modulation of neurotransmission in the guinea pig vas deferens preparation.
Hall JM; Morton IK
Ann N Y Acad Sci; 1991; 632():404-6. PubMed ID: 1719888
[No Abstract] [Full Text] [Related]
13. Pharmacological properties of a potent and selective nonpeptide substance P antagonist.
Garret C; Carruette A; Fardin V; Moussaoui S; Peyronel JF; Blanchard JC; Laduron PM
Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10208-12. PubMed ID: 1719549
[TBL] [Abstract][Full Text] [Related]
14. Receptor-mediated specific biological activity of a beta-amyloid protein fragment for NK-1 substance P receptors.
Shimohigashi Y; Matsumoto H; Takano Y; Saito R; Iwata T; Kamiya H; Ohno M
Biochem Biophys Res Commun; 1993 Jun; 193(2):624-30. PubMed ID: 7685598
[TBL] [Abstract][Full Text] [Related]
15. Actinomycin D is a competitive and selective antagonist at NK2 tachykinin receptors.
Patacchini R; Astolfi M; Brown MC; Maggi CA
Neuropeptides; 1991 Oct; 20(2):109-14. PubMed ID: 1665895
[TBL] [Abstract][Full Text] [Related]
16. Effects of tachykinins and capsaicin on the mechanical and electrical activity of the guinea-pig isolated trachea.
Girard V; Félétou M; Advenier C; Canet E
Br J Pharmacol; 1997 Nov; 122(5):841-8. PubMed ID: 9384499
[TBL] [Abstract][Full Text] [Related]
17. Effect of thiorphan on tachykinin-induced potentiation of nerve-mediated contractions of the rat isolated vas deferens.
Patacchini R; Maggi CA; Rovero P; Regoli D; Drapeau G; Meli A
J Pharmacol Exp Ther; 1989 Aug; 250(2):678-81. PubMed ID: 2547944
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of dimeric analogs of neurokinin A and B: effect of dimerization of COOH-terminal heptapeptides on receptor selection.
Sakaguchi K; Kodama H; Matsumoto H; Yoshida M; Takano Y; Kamiya H; Waki M; Shimohigashi Y
Pept Res; 1989; 2(5):345-51. PubMed ID: 2485210
[TBL] [Abstract][Full Text] [Related]
19. Selective agonists of NK-2 binding sites highly active on rat portal vein (NK-3 bioassay).
Chassaing G; Lavielle S; Loeuillet D; Robilliard P; Carruette A; Garret C; Beaujouan JC; Saffroy M; Petitet F; Torrens Y
Neuropeptides; 1991 Jun; 19(2):91-5. PubMed ID: 1658676
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of neurokinin receptors with agonists and antagonists.
Regoli D; Nguyen QT; Jukic D; Rouissi N
Regul Pept; 1993 Jul; 46(1-2):287-9. PubMed ID: 7692518
[No Abstract] [Full Text] [Related]
[Next] [New Search]
